Tech Company Financing Transactions
Topaz Pharmaceuticals Funding Round
Topaz Pharmaceuticals, operating out of Horsham, raised $20 million from Aisling Capital and F-Prime Capital.
Transaction Overview
Company Name
Announced On
12/4/2007
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Proceeds Purpose
The funds will be used to help Topaz complete clinical trials of the company's new prescription medicine to fight head lice, and prepare the product for market.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
100 Witmer Road 280
Horsham, PA 19034
USA
Horsham, PA 19034
USA
Phone
Website
Email Address
Overview
Topaz Pharmaceuticals is developing a completely novel and kid friendly formulation of a naturally derived, quick acting ingredient which is lethal to head and body lice.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bob Radie
Chief Financial Officer
Reid McCarthy
Chief Medical Officer
Thomas Beck
VP - Bus. Development
Mark Strobeck
VP - Operations
Robert Verdugo
VP - Regulatory Affairs
Lisa DeLuca
Browse more venture capital transactions:
Prev: 12/4/2007: WiTricity venture capital transaction
Next: 12/5/2007: CrossLoop venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs